[Antiprotozoal drugs].
Nakajima
Yasuo
Y
Department of Parasitology and Immunology, Yamanashi Medical University.
D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D004338:Drug Combinations; D004640:Emetine / Q000031:analogs & derivatives*; D006801:Humans; D015767:Mefloquine; D008795:Metronidazole; D010616:Phenanthrenes; D011319:Primaquine; D011528:Protozoan Infections / Q000188:drug therapy / Q000469:parasitology; D011739:Pyrimethamine; D011803:Quinine; D013413:Sulfadoxine; D014011:Tinidazole
D000981:Antiprotozoal Agents; D004338:Drug Combinations; D010616:Phenanthrenes; D014011:Tinidazole; D008795:Metronidazole; C001205:fanasil, pyrimethamine drug combination; C086742:dehydroemetine; D013413:Sulfadoxine; D011803:Quinine; D011319:Primaquine; C023768:halofantrine; D015767:Mefloquine; D004640:Emetine; D011739:Pyrimethamine